Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 4-15

Bentham Science Publishers

Access to resources Recommend Favorite

Alternating chemo-immunotherapy with temozolomide and interleukin-2 in the treatment of metastatic melanoma

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A Role of Immunotherapy in Metastatic Malignant Melanoma

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

By Ackerman Allison   Klein Oliver   McDermott David F.   Wang Wei   Ibrahim Nageatte   Lawrence Donald P.   Gunturi Anasuya   Flaherty Keith T.   Hodi F. Stephen   Kefford Richard   Menzies Alexander M.   Atkins Michael B.   Long Georgina V.   Sullivan Ryan J.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1695-1701

Blackwell Publishing

Access to resources Recommend Favorite

Immunotherapy of Melanoma

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 196-207

Bentham Science Publishers

Access to resources Recommend Favorite